Natco Pharma Limited on Friday announced the share buyback schedule commencing on November 19. Last week, the company board decided to buy back shares for a price of Rs 1,000 per share from the open market by spending a maximum of Rs 2.5 billion.
While announcing the schedule, the company said the buyback of shares to an extent of at least 50 per cent of the amount earmarked for this purpose would be completed within six months from the scheduled buyback date. The price of shares determined for buyback comes at a premium of little over 40 per cent of the closing price of company shares on October 26, 2018.
The company has proposed to buy a minimum number of 1.25 million shares from the open market route in the six-month period.
The promoters and promoter group hold 48.25 per cent shares in the company, while 24.31 per cent equity shares are held by foreign institutional investors under the public shareholding classification.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)